Respiratory Tract Infections News and Research

RSS

The number of deaths attributable to second hand smoke exposure has increased between 1990 and 2019

Researchers estimated the prevalence of and assessed trends in exposure to second-hand smoke (SHS)

2 Aug 2023

Machine learning's potential for rapid LRTI diagnosis

A team of researchers evaluated the use of prediction models in LRTI diagnosis.

17 Jul 2023

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Eli Lilly and Company announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation (MA) for mirikizumab (OMVOH®) for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

10 Jul 2023

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.

10 Jul 2023

Medicaid Expansion led to increased access to preventive care for low-income adults

People with low incomes who live in states that expanded Medicaid got more of the kind of health care that can keep them healthier in the long run, compared with similar people in non-expansion states, a new study finds.

7 Jul 2023

Global efforts to reduce infectious diseases must include older children and adolescents

Global efforts to reduce infectious disease rates must have a greater focus on older children and adolescents after a shift in disease burden onto this demographic, according to a new study.

4 Jul 2023

Battle against RSV: Computational design paves way for new polyvalent vaccine

Research focuses on the design of a multi-epitope polyvalent vaccine against Human Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract infections. The study utilizes computational methods and immunoinformatics tools to predict potential vaccine candidates and their interactions with Toll-like receptors (TLRs).

19 Jun 2023

Interventions based on Choosing Wisely guidelines can reduce antibiotic overuse at safety-net hospitals

A statewide pay-for-performance intervention based on a set of guidelines called Choosing Wisely reduced rates of inappropriate antibiotic prescriptions to treat acute respiratory tract infections by an average of 18 percentage points, from 43% to 25%, across two large Los Angeles safety net hospitals.

12 Jun 2023

Spike in childhood human metapneumovirus infections in Western Australia linked to reduced COVID-19 measures

Researchers investigated the prevalence of human metapneumovirus through 2020 considering the implementation of NPIs due to the COVID-19 pandemic.

31 May 2023

NmCV-5 vaccine safety and immunogenicity against bacterial meningitis in Mali and Gambia

Researchers evaluated the safety and non-inferiority of the pentavalent meningococcal NmCV-5 vaccine.

30 May 2023

What is the subsequent risk of mental disorders among individuals with SARS-CoV-2 infection, and are the associations specific for COVID-19?

Researchers estimated psychiatric disorders and psychotropic medication usage risks among SARS-CoV-2-infected.

30 May 2023

Ethanol vapor inhalation can disable influenza A virus in mice

Inhaling low concentrations of ethanol vapor can disable the influenza A virus in mice, without harmful side effects, says a new study by scientists at the Okinawa Institute of Science and Technology (OIST). The scientists believe it may also treat similar viruses such as the one that causes Covid-19.

27 Apr 2023

Soaring healthcare costs for RSV-related complications in US seniors 60 plus

In a recent study published in the journal Open Forum Infectious Diseases, researchers explored the correlation between complications caused by a respiratory syncytial virus (RSV) and the associated healthcare costs.

18 Apr 2023

The economic burden of RSV infections in low and middle-income countries

Researchers discuss the cost-of-illness associated with RSV infections among children in low and middle-income countries.

6 Apr 2023

New method for lower respiratory tract infection diagnosis in critically ill children

Lower respiratory tract infection (LRTI), which includes conditions such as pneumonia, has long been the leading cause of death from communicable agents and a leading cause of death in children worldwide.

5 Apr 2023

Next-generation influenza vaccines show greater impact and cost-effectiveness, study suggests

In a recent study published in the BMC Medicine Journal, researchers conducted a modeling study to evaluate the cost-effectiveness and health impacts of the next-generation vaccines against influenza in Kenya.

28 Mar 2023

Study finds unusual peak in RSV hospitalizations in late 2021

The COVID-19 pandemic posed an immense challenge on the health care industry in 2020 and 2021. While hospitals were inundated with COVID-19 cases, other illnesses such as respiratory syncytial virus (RSV) saw a decrease in hospital visits, particularly in the fourth quarter of 2020 and the first quarter of 2021.

28 Mar 2023

Individuals with autosomal and X-linked recessive deficiency of IRAK-4 and MyD88 are more susceptible to developing hypoxemic COVID-19 pneumonia

Researchers identified that individuals with a deficiency of myeloid differentiation primary response 88 (MyD88) and interleukin-1 receptor-associated kinase 4 (IRAK-4) due to an autosomal recessive condition were highly susceptible to developing hypoxemic coronavirus disease 2019 (COVID-19) pneumonia when infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

9 Mar 2023

Immunomodulatory effects of biotics-supplemented infant formulas

A review article published in the journal Nutrients describes the effects and benefits of pre-, pro-, syn-, and postbiotics-containing infant formulas in terms of modulating gut microbiota, immune response, and allergy susceptibility of newborns and infants.

1 Mar 2023

Oral fluid shows excellent potential for epidemiological surveillance of respiratory pathogens

Announcing a new article publication for Zoonoses journal. Oral fluid (OF) is a new safe, non-invasive, convenient, and efficient biological sample that can be used for virus nucleic acid and antibody detection.

24 Feb 2023